These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 578315)

  • 1. An introductory study of the influence and role of prolactin in mammary tumor growth.
    Duncan KL; Don BR; Schaeffer LD; Puffer HW; Lee YT; Warner NE
    Proc West Pharmacol Soc; 1977; 20():195-7. PubMed ID: 578315
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.
    Diamond EJ; Koprak S; Shen SK; Hollander VP
    Cancer Res; 1976 Jan; 36(1):77-80. PubMed ID: 1248010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of perphenazine-induced serum prolactin response on estrogen-primed mammary tumor-host systems, 13762 and R-35 mammary adenocarcinomas.
    Bogden AE; Taylor DJ; Kuo EY; Mason MM; Speropoulos A
    Cancer Res; 1974 Nov; 34(11):3018-25. PubMed ID: 4419558
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary lipid effects on the growth, membrane composition, and prolactin-binding capacity of rat mammary tumors.
    Cave WT; Jurkowski JJ
    J Natl Cancer Inst; 1984 Jul; 73(1):185-91. PubMed ID: 6330421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumor virus potentiation of endogenous prolactin effect on mammary gland differentiation.
    Ben-David M; Heston WE; Rodbard D
    J Natl Cancer Inst; 1969 Feb; 42(2):207-18. PubMed ID: 4303880
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of carcinogen-induced mammary tumor growth in rats by adrenalectomy.
    Chen HJ; Bradley CJ; Meites J
    Cancer Res; 1976 Apr; 36(4):1414-7. PubMed ID: 816463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain.
    Ren X; Zhang X; Kim AS; Mikheev AM; Fang M; Sullivan RC; Bumgarner RE; Zarbl H
    Carcinogenesis; 2008 Jan; 29(1):177-85. PubMed ID: 17916903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
    Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
    Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin regulation of cryptic prolactin receptors in cultured rat mammary tumor cells.
    Costlow ME; Hample A
    J Cell Physiol; 1984 Mar; 118(3):247-52. PubMed ID: 6321522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
    Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
    Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of thyroidectomy and prolactin suppression on the growth of N-nitrosomethylurea-induced rat mammary carcinomas.
    Rose DP; Mountjoy KG
    Cancer Res; 1983 Jun; 43(6):2588-91. PubMed ID: 6850579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrest of synthesis of specific proteins at the onset of mammary tumor regression.
    Rouleau M; Losonczy I; Gullino PM
    Cancer Res; 1978 Apr; 38(4):926-31. PubMed ID: 639047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
    Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin-dependent rat mammary cancer: a model for man?
    Pearson OH; Llerena O; Llerena L; Molina A; Butler T
    Trans Assoc Am Physicians; 1969; 82():225-38. PubMed ID: 5375151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ; Kledzik GS; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on apoptosis induction in cultured breast cancer cells derived from breast cancer of HTLV-I pX transgenic rats].
    Shikishima H
    Hokkaido Igaku Zasshi; 2004 Nov; 79(6):639-46. PubMed ID: 15675294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.